FDA Inspection 1035957 — Henan Lihua Pharmaceutical Co., Ltd.
The FDA completed an inspection of Henan Lihua Pharmaceutical Co., Ltd. on December 14, 2017 in Anyang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 14, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Anyang (China)